Emergent BioSolutions, announced a sharpened strategic focus on its core businesses, consisting of medical countermeasures (MCM) and commercial products, including NARCAN (naloxone HCl) Nasal Spray, as well as contract development and manufacturing (CDMO) services. 
 

“Emergent is undertaking these actions to strengthen our business, reduce costs and return to sustainable, long-term growth,” said Emergent President and CEO Robert Kramer. “Sharpening our focus on our core products and services will also allow Emergent to have the most impact for the most patients, stay true to our mission to protect and enhance life and ensure that Emergent continues to be a vital contributor to public health well into the future.”
 

The actions, in combination with other cost reduction initiatives, are expected to result in annualized savings of over $60 million when fully implemented. The costs associated with these actions are estimated to be approximately $9 million – $11 million and are expected to be incurred in the first quarter of 2023.
 

Among the strategic developments:

 

• The appointment of Paul Williams, Emergent’s current SVP government/MCM business, as Senior Vice President, Products Business to lead the company’s MCM and commercial products business, including NARCAN Nasal Spray. 
 

• Newly created Science and Development (S&D) function that unites research, product development, and clinical teams. The realigned S&D team will focus on programs that support our life cycle plans for our licensed products while growing the products and services businesses over the long term.
 

• Elimination of 132 roles related to the S&D consolidation and other organizational changes representing approximately 5% of the current corporate workforce.
 

The company also announced the departure of Atul Saran, EVP and Chief Strategy and Development Officer and Katy Strei, EVP and Chief Human Resource Officer.
 

Strategy and Development teams will now report to Stephanie Duatschek, Chief Strategy and Transformation Officer while Michelle Pepin has been promoted to Senior Vice President and Chief Human Resource Officer.